Search results for: 'research area tyrosine kinase insulin receptor'
- A2678 SU112742 CitationTarget: METSummary: C-Met inhibitor,potent and selective
- A4302 Rosiglitazone maleateTarget: Insulin and Insulin-like ReceptorsSummary: PPARγ agonist,high-affinity and selective,potent insulin sensitizer
- A1821 Ki8751Target: VEGFRSummary: VEGFR-2 inhibitor,potent and selective
- A4150 WHI-P154Target: VEGFR|Src|EGFR|JAKSummary: JAK3 inhibitor
- B5516 5'-FluoroindirubinoximeSummary: FMS-like receptor tyrosine kinase-3 (FLT3) inhibitor
- BA8865 AZD3229Summary: AZD3229 is a potent and broadly available mutant tyrosine kinase receptor inhibitor for developmental studies of gastrointestinal mesenchymal tumors.
- BA8948 IrpagratinibSummary: Irpagratinib (ABSK011) is an orally active inhibitor of fibroblast growth factor receptor (FGFR) tyrosine kinase, targeted (IC50<10nM).
- A3962 AZD1208Target: PimSummary: PIM kinase inhibitor
- BA4909 Tyk2-IN-5Summary: Tyk2-IN-5 is a potent, selective and orally active tyrosine kinase 2 inhibitor.
- BA6066 LarotinibSummary: Larotinib is a potent, broad-spectrum, orally active tyrosine kinase inhibitor (TKI).